More radiation may decrease breast cancer recurrence risk in some patients
the ONA take:
After conservation surgery, some women who undergo additional radiation given to the lymph nodes along with whole-breast irradiation may be at a reduced risk of breast cancer recurrence, according to a study in the New England Journal of Medicine.
Researchers led by Tim Whelan, MD, of McMaster University’s Michael G. DeGroote School of Medicine looked at women with axillary node-positive or high-risk node-negative breast cancer in order to determine whether adding regional node irradiation to whole-breast irradiation proved more beneficial than whole-breast irradiation alone.
More than 1,800 patients were included in the 14-year study as part of NCIC Clinical Trials Group at Queen’s University in Ontario.
They found that additional radiation to the surrounding lymph nodes reduced risk of subsequence recurrence both locally and at sites distant from the breast.
“This study is important because it shows that additional radiation to the surrounding lymph nodes provides added benefit to women, particularly those with involvement of the lymph nodes in the axilla,” Dr. Whelan said. “Further research is necessary to determine which women are most likely to benefit and who may avoid the additional radiation.”
Some women who undergo additional radiation along with whole-breast irradiation may be at a reduced risk of breast cancer recurrence.
Sign Up for Free e-newsletters
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|